NCT02532673View on ClinicalTrials.gov

Impact of Hyperbilirubinemia Among HIV Patients Treated With Atazanavir

CompletedOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
HIV/AIDS
Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY